University of Calgary
Also known as: ACHIEVE Research, Alberta Children's Hospital, University of Calgary and Alberta Health Services | AHS Calgary | AHS Cancer Control Alberta | AHS-CCI | Alberta Children's Hospital | Alberta Children's Hospital Research Institute, University of Calgary | Alberta Children's Hospital, Southern Alberta Children's Cancer Program, AB Canada | Alberta children's Hospital/University of Calgary | Alberta Children's Hospital, University of Calgary | Alberta Children's Hospital, University of Calgary, KidSIM | Alberta Health Services | Alberta Health Services, Calgary | Alberta Health Services - Cross Cancer Institute | Alberta Health Services, Edmonton | Anthony Seto | Barry Baylis | Belal Alshaikh | Calgary Health Region | Calgary Health Trust | Calgary West Medical Centre | Calgary West Medical Centre Clinical Studies | Chairman, University of Calgary Spine Program | Cumming school of medicine | Cumming School of Medicine, University of Calgary | Department of Clinical Neurosciences, University of Calgary | Department of Community Health Sciences, University of Calgary | Department of Oncology, Cross Cancer Institute, Cancer Care, Alberta Health Services | Dept of Clinical Neurosciences, University of Calgary | Depts. of Paediatrics and Community Health Sciences, University of Calgary | Director, Inflammatory Bowel Disease Clinic, Associate Professor of Medicine, University of Calgary, Calgary, AB, Canada | Division of Otolaryngology, University of Calgary | Dr. Bob Sheldon | Dr. Luanne Metz | Dr. Michael Hill | Foothills Hospital | Foothills Hospital, Calgary, Canada | Foothills Hosptial | Foothills Interventional Cardiology Group | Foothills Medical Center | Foothills Medical Centre, Div. of Transplant Surgery | Foothills Medical Centre, University of Calgary | Harish Amin | Hotchkiss Brain Institute, University of Calgary | Jason Martyn | Professor, University of Calgary | Respiratory Clinical Trials Centre, University of Calgary | Sarah Williamson-Urquhart | Sport Injury Prevention Research Centre | Sport Injury Prevention Research Centre, University of Calgary | Study Principal Investigator, University of Calgary | The University of Calgary | Tom Baker Cancer Board | Tom Baker Cancer Center | Tom Baker Cancer Centre | Tom Baker Cancer Centre - Calgary | Tom Baker Cancer Centre, Calgary AB | Tom Baker Cancer Centre, Calgary, Alberta | Tom Baker Cancer Centre, Calgary Alberta Canada | Tom Baker Cancer Centre, Calgary, Alberta, Canada | Tom Baker Cancer Centre, Calgary, Canada | Tom Baker Cancer Centre, University of Calgary | University Of Calagary | University of Calgary | University of Calgary, Alberta, Canada | University of Calgary and Alberta Health Services | University of Calgary and Calgary Health Region | University of Calgary and Foothills Medical Centre | University of Calgary, Calgary, Alberta, Canada | University of Calgary, Calgary, Alberta, Canada. | University of Calgary Cumming School of Medicine | University of Calgary - Department of Anesthesia | University of Calgary - Department of Pediatrics | University of Calgary Faculty of Medicine | University of Calgary, Faculty of Medicine | University of Calgary Foothills Medical Center | University of Calgary, Libin Cardiovascular Institute | U of Calgary
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1994Last known activity
Feb 2, 2026
Timeline
1900s
- Jan 1, 1908
University of Calgary— Founded
Drugs by trial phase (342 distinct, 394 trials)
Phase 4 (75 own, 0 via acquisition)
Phase 3 (92 own, 0 via acquisition)
Phase 2 (123 own, 0 via acquisition)
Phase 1 (22 own, 0 via acquisition)
Other trials (30 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Disease
- Acute Pain
- Adenocarcinoma
- Amyotrophic Lateral Sclerosis
- Anemia, Aplastic
- Anemia, Sickle Cell
- Aneurysm
- Anorexia
- Anus Neoplasms
- Apnea
- Arsenic Poisoning
- Arthralgia
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Atherosclerosis
- Atrial Fibrillation
- Balanitis
- Biliary Tract Neoplasms
- Bone Diseases
- Bone Diseases, Metabolic
- Brain Diseases
- Brain Infarction
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Brain Neoplasms
- Breakthrough Pain
- Breast Neoplasms
- Bronchitis
- Cancer Pain
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cardiac Complexes, Premature
- Cardiomyopathies
- Cardiomyopathy, Hypertrophic
- Cardiovascular Diseases
- Central Nervous System Diseases
- Central Nervous System Neoplasms
- Cerebral Hemorrhage
- Cerebral Infarction
- Cerebrovascular Disorders
- Cholestasis
- Chondrosarcoma
- Chronic Pain
- Clostridium Infections
- Colorectal Neoplasms
- Communicable Diseases
- Congenital Hyperinsulinism
- Contracture
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Cystic Fibrosis
- Cystitis
- Death
- Death, Sudden, Cardiac
- Deglutition Disorders
- Dehydration
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetic Nephropathies
- Diabetic Neuropathies
- Diarrhea
- Digestive System Neoplasms
- Disease
- Drug Resistant Epilepsy
- Ductus Arteriosus, Patent
- Dupuytren Contracture
- Dystonia
- Dystonic Disorders
- Emergencies
- Endometrial Neoplasms
- Enterocolitis
- Enthesopathy
- Epilepsies, Partial
- Epilepsy
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Fibrosis
- Flushing
- Gambling
- Gastroenteritis
- Gastrointestinal Neoplasms
- Gastroparesis
- Glioblastoma
- Graft vs Host Disease
- Headache
- Headache Disorders, Secondary
- Head and Neck Neoplasms
- Heart Failure
Recent trials (50)
- NCT06924827CollaboratorPhase 4Feb 2, 2026
- NCT07297667OfficialPhase 1Jan 31, 2026
- NCT06790589Lead sponsorPhase 2Dec 31, 2025
- NCT06860542Lead sponsorPhase 2Dec 1, 2025
- NCT07140484CollaboratorPhase 4Oct 6, 2025
- NCT06882174Lead sponsorPhase 2Oct 6, 2025
- NCT06785272CollaboratorPhase 3Sep 30, 2025
- NCT07145645OfficialPhase 3Sep 2, 2025
- NCT07145645Lead sponsorPhase 3Sep 2, 2025
- NCT06942208Sponsor investigatorN/ASep 1, 2025
- NCT06942208OfficialN/ASep 1, 2025
- NCT06942208Lead sponsorN/ASep 1, 2025
- NCT07084298Lead sponsorEarly Phase 1Aug 31, 2025
- NCT07084298OfficialEarly Phase 1Aug 31, 2025
- NCT07084298Sponsor investigatorEarly Phase 1Aug 31, 2025
Details
- Founded
- Calgary, Alberta, CA Jan 1, 1908
- Last known activity
- Feb 2, 2026